Daily Judi

Daily Judi: Tuesday, November 29, 2022

Every day we scan the headlines for the best items that engage the clinical trial ecosystem, workflow solutions, and more—all the latest news you need to know. Here are today's stories:

The Pew Research Center surveys clinical trial participation and equitable engagement.

AstraZeneca is acquiring Neogene Therapeutics in a deal worth over $200 million. Neogene's T-cell receptor therapies are designed to target solid tumors. (Fierce Biotech)

In a controlled trial with funding from the NIH National Institute on Aging, and conducted by researchers at Duke University School of Medicine and Columbia University, computer crossword puzzles performed better than other computer games at improving cognition in people over 70. (Duke University School of Medicine)

Our Culture

“We work proactively with each client, analyzing our reports to make them work faster, to help make our client’s life better.”

   –Tim, Trial Delivery

About Judi

Judi speeds and improves the world's clinical trial workflows. Our cloud-based platform has 120,000 users across 168 countries. We eliminate the chaos so clinical teams can focus on the patient, rather than the process. We are a SOC 2 Type II certified collaboration platform.

No tags found.

Stay up-to-date with whats happening

Some sub copy covering what weekly/monthly update sand news one can expect.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.